STADA: Purchase of a generics business in Switzerland successfully concluded
31/01/2012
STADA: Purchase of a generics business in Switzerland successfully concluded
Related Posts
STADA’s Strong Growth Journey Continues in 2025
STADA in 2025 again demonstrated the success of its three-segment strategy, that provides patients and healthcare professionals with a broad range of medicines and healthcare products
STADA invests more than €85m in Saudi Arabia manufacturing hub
Global healthcare company STADA today committed to investing more than €85 million in a state-of-the-art manufacturing facility in Saudi Arabia
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
STADA and Bio-Thera Solutions have received a marketing authorization from the European Commission
